Giovanni Melillo

Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia

G. Melillo, A. Rapisarda, Annamaria Rapisarda, 2012, Nature Reviews Clinical Oncology.

Application of high-throughput, molecular-targeted screening to anticancer drug discovery.

D. Scudiero, E. Sausville, D. Covell, 2002, Current topics in medicinal chemistry.

Inhibiting Hypoxia-Inducible Factor 1 for Cancer Therapy

G. Melillo, Giovanni Melillo, 2006, Molecular Cancer Research.

Durvalumab after Chemoradiotherapy in Stage III Non–Small‐Cell Lung Cancer

Tarek Mekhail, Maike de Wit, Kaoru Kubota, 2017, The New England journal of medicine.

Identification of a new natural camptothecin analogue in targeted screening for HIF-1alpha inhibitors.

John H Cardellina, D. Scudiero, R. Shoemaker, 2006, Planta medica.

Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1α.

Henry Yang, Kaibo Duan, Michael Poidinger, 2015, Immunity.